BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 38711788)

  • 1. Safe Injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego-Tijuana border region.
    Bailey K; Abramovitz D; Rangel G; Harvey-Vera A; Vera CF; Patterson TL; Arredondo Sánchez-Lira J; Davidson PJ; Garfein RS; Smith LR; Pitpitan EV; Goldenberg SM; Strathdee SA
    medRxiv; 2024 May; ():. PubMed ID: 38826285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water, sanitation and hygiene insecurity predict abscess incidence among people who inject drugs in a binational US-Mexico metropolitan area: A longitudinal cohort study.
    Calderón-Villarreal A; Abramovitz D; Avelar Portillo LJ; Goldenberg S; Flanigan S; Quintana PJE; Harvey-Vera A; Vera CF; Rangel G; Strathdee SA; Kayser GL
    Int J Drug Policy; 2024 Jun; 129():104485. PubMed ID: 38901113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual and drug use behaviors associated with HIV and other sexually transmitted infections among female sex workers in the Mexico-US border region.
    Ulibarri MD; Strathdee SA; Patterson TL
    Curr Opin Psychiatry; 2010 May; 23(3):215-20. PubMed ID: 20308903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Working With Persons Who Inject Drugs and Live in Rural Areas: Implications From China/Vietnam for the USA.
    Des Jarlais DC; Hammett TM; Kieu B; Chen Y; Feelemyer J
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):302-307. PubMed ID: 29948610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 transmission dynamics among people who inject drugs on the US/Mexico border during the COVID-19 pandemic: a prosepective cohort study.
    Skaathun B; Strathdee SA; Shrader CH; Nacht CL; Borquez A; Artamonova I; Harvey-Vera A; Vera CF; Rangel G; Ignacio C; Woodworth B; Chaillon A; Vasylyeva TI
    Lancet Reg Health Am; 2024 May; 33():100751. PubMed ID: 38711788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.
    Strathdee SA; Abramovitz D; Harvey-Vera A; Vera CF; Rangel G; Artamonova I; Chaillon A; Ignacio C; Calderon A; Martin NK; Patterson TL
    PLoS One; 2021; 16(11):e0260286. PubMed ID: 34807963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Transmission Networks in the San Diego-Tijuana Border Region.
    Mehta SR; Wertheim JO; Brouwer KC; Wagner KD; Chaillon A; Strathdee S; Patterson TL; Rangel MG; Vargas M; Murrell B; Garfein R; Little SJ; Smith DM
    EBioMedicine; 2015 Oct; 2(10):1456-63. PubMed ID: 26629540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study.
    Borquez A; Beletsky L; Nosyk B; Strathdee SA; Madrazo A; Abramovitz D; Rafful C; Morales M; Cepeda J; Panagiotoglou D; Krebs E; Vickerman P; Claude Boily M; Thomson N; Martin NK
    Lancet Public Health; 2018 Sep; 3(9):e429-e437. PubMed ID: 30122559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.
    Robertson AM; Garfein RS; Wagner KD; Mehta SR; Magis-Rodriguez C; Cuevas-Mota J; Moreno-Zuniga PG; Strathdee SA;
    Harm Reduct J; 2014 Feb; 11():4. PubMed ID: 24520885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Knaul FM; Arreola-Ornelas H; Touchton M; McDonald T; Blofield M; Avila Burgos L; Gómez-Dantés O; Kuri P; Martinez-Valle A; Méndez-Carniado O; Nargund RS; Porteny T; Sosa-Rubí SG; Serván-Mori E; Symes M; Vargas Enciso V; Frenk J
    Lancet; 2023 Aug; 402(10403):731-746. PubMed ID: 37562419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California.
    Bailey K; Abramovitz D; Artamonova I; Davidson P; Stamos-Buesig T; Vera CF; Patterson TL; Arredondo J; Kattan J; Bergmann L; Thihalolipavan S; Strathdee SA; Borquez A
    Int J Drug Policy; 2023 Aug; 118():104086. PubMed ID: 37295217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the Fundamental Drivers of Phylodynamic Inference.
    Featherstone LA; Duchene S; Vaughan TG
    Mol Biol Evol; 2023 Jun; 40(6):. PubMed ID: 37264694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-level HIV risk norms are associated with individual-level HIV risk and harm reduction behaviors among people who inject drugs: a latent profile analysis.
    Shrader CH; Borquez A; Vasylyeva TI; Chaillon A; Artamanova I; Harvey-Vera A; Vera CF; Rangel G; Strathdee SA; Skaathun B
    AIDS Behav; 2023 Feb; 27(2):484-495. PubMed ID: 35939177
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.